Bruker Corporation (BRKR) 22.37 $BRKR Bruker an
Post# of 273254
Posted On: 09/26/2016 1:11:12 AM
Bruker Corporation (BRKR) 22.37 $BRKR
Bruker and 3M Expand Exclusive License for Processing of FFPE Tissue Sections to Routine Pathology
PR Newswire - Sun Sep 25, 3:30AM CDT
At the 28th Congress of the European Society of Pathology, Bruker today announces that it has expanded its license agreement with 3M for processing of FFPE tissue sections.
BRKR: 22.37 (-0.18)
Bruker Introduces the new TRACER 5i Handheld XRF Elemental Analyzer System for Advanced Applications and Research
PR Newswire - Thu Sep 15, 6:00AM CDT
Bruker today introduces the new TRACER(TM) 5i handheld X-ray fluorescence (XRF) elemental analyzer. The new TRACER 5i is more sensitive, flexible and field interactive, while retaining the unique advantages and comprehensive analytical software that the previous TRACER model has been recognized for. The new TRACER 5i incorporates a more powerful tube and detector, an automated filter wheel and a manual filter slot, selectable collimation, Bruker's patented SharpBeam(TM) optimized geometry, pressure and temperature compensation, an internal VGA CMOS camera, an interactive touchscreen with point-and-shoot capability, and Wi-Fi & Bluetooth connectivity.
BRKR: 22.37 (-0.18)
SENAI Outfits New Tribology Lab with Bruker UMT TriboLab Systems
PR Newswire - Tue Sep 13, 6:00AM CDT
Bruker has announced the installation of six UMT TriboLab Mechanical Testers at the Tribology Laboratory of Innovation SENAI Institute for Surface Engineering in Belo Horizonte, Brazil. Established by Brazil's National Service of Industrial Training (SENAI), the new state-of-the-art laboratory will utilize the TriboLab systems to carry out research and development of products focused on the evaluation of materials performance for resistance to wear. The TriboLab systems enable the new laboratory to test real-use conditions across an extremely wide range of industrial products, from automotive engine components and hydraulic pumps to cutting tools and aeronautical turbines.
BRKR: 22.37 (-0.18)
Bruker to Buy Oncovision's Preclinical Imaging Business
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 9:48AM CDT
Bruker entered into an agreement to acquire Oncovision's preclinical PET (Positron Emission Tomography) imaging business.
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), BRKR: 22.37 (-0.18), NUVA: 66.77 (-1.29)
Bruker Signs Agreement to Acquire Oncovision's Preclinical PET Imaging Business
PR Newswire - Wed Sep 07, 6:00AM CDT
Bruker today announced that it has signed an agreement to acquire the preclinical imaging business of Oncovision, a leading provider of innovative medical imaging devices used for the diagnosis of cancer. Financial terms of the agreement were not disclosed.
BRKR: 22.37 (-0.18)
Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress
PR Newswire - Wed Sep 07, 6:00AM CDT
Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 (WMIC: http://www.wmis.org) in New York. The new systems are designed to deliver highest performance and improved convenience for routine imaging, and enable novel translational research into the causes, progression, as well as potential diagnosis and treatment of disease.
BRKR: 22.37 (-0.18)
Research Reports Initiation on Medical Laboratories & Research Stocks -- Quest Diagnostics, Bruker, Organovo, and Alere
PR Newswire - Wed Aug 31, 7:00AM CDT
Stock-Callers.com draws investors' attention to these Medical Laboratories and Research equities: Quest Diagnostics Inc. (NYSE: DGX), Bruker Corp. (NASDAQ: BRKR), Organovo Holdings Inc. (NASDAQ: ONVO), and Alere Inc. (NYSE: ALR). Industry growth is influenced by a number of trends, which include demographics, emerging economies, biotech advances in genetics, and pathogen evolution. Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
ONVO: 3.97 (-0.03), DGX: 85.44 (-0.29), BRKR: 22.37 (-0.18), ALR: 43.24 (-0.43)
Bruker Corporation to Present at Investor Conferences
PR Newswire - Wed Aug 31, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:
BRKR: 22.37 (-0.18), WFC: 45.74 (+0.02)
Short Interest In Bruker Declines 17%
MarketNewsVideo.com - Thu Aug 25, 2:29PM CDT
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 751,751 share decrease in total short interest for Bruker Corp , to 3,678,038, a decrease of 16.97% since 07/29/2016. Total short interest is...
BRKR: 22.37 (-0.18)
Bruker's Q2 Results Disappoint, Product Launches Continue
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:14AM CDT
On Aug 12, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), BRKR: 22.37 (-0.18), NUVA: 66.77 (-1.29)
FlavorActiV and Bruker Announce Flavor Stability Partnership at World Brewing Congress
PR Newswire - Mon Aug 15, 8:30AM CDT
At the World Brewing Congress (www.worldbrewingcongress.org) in Denver, USA, FlavorActiV and Bruker Corporation (NASDAQ: BRKR) announced their strategic partnership and the launch of the Flavor Stability Package, by combining world-class beer sensory know-how with consistent tools and proven Bruker e-scan(TM) EPR technology.
BRKR: 22.37 (-0.18)
Bruker Announces Quarterly Dividend
PR Newswire - Tue Aug 09, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on September 23, 2016 to stockholders of record as of September 6, 2016.
BRKR: 22.37 (-0.18)
Bruker (BRKR) Posts In-Line Q2 Earnings, Misses Sales
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:29AM CDT
Bruker's (BRKR) second quarter earnings came in line with the Zacks Consensus Estimate, while revenues missed the mark.
BABY: 43.99 (-0.39), MASI: 59.77 (-0.55), BRKR: 22.37 (-0.18), IDXX: 111.36 (-1.73)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:52AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Outperform to Market Perform at Wells Fargo today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. Bruker share prices have moved between a 52-week high of $29.85 and a 52-week low of $15.78 and closed yesterday at 38% above that low price at $21.79 per share. The 200-day and 50-day moving averages have moved 0.62% higher and 0.71% higher over the past week, respectively.
BRKR: 22.37 (-0.18)
Upgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:50AM CDT
Bruker (NASDAQ:BRKR) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. There is potential upside of 2.0% for shares of Bruker based on a current price of $21.79 and an average consensus analyst price target of $22.23. The stock should find initial resistance at its 200-day moving average (MA) of $22.60 and further resistance at its 50-day MA of $28.13.
BRKR: 22.37 (-0.18)
SmarTrend Watching for Potential Rebound in Shares of Bruker After 12.06% Loss
Comtex SmarTrend(R) - Wed Aug 03, 1:56PM CDT
Bruker (NASDAQ:BRKR) traded in a range yesterday that spanned from a low of $21.38 to a high of $22.93. Yesterday, the shares fell 12.1%, which took the trading range below the 3-day low of $24.31 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BRKR: 22.37 (-0.18)
Bruker Reports Second Quarter 2016 Financial Results
PR Newswire - Tue Aug 02, 3:05PM CDT
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its second quarter ended June 30, 2016.
BRKR: 22.37 (-0.18)
Bruker Acquires Software Assets for Next-Generation Automated and Quantitative Mineral Identification and Characterization
PR Newswire - Mon Jun 20, 6:00AM CDT
Bruker today announced that it has acquired the assets of Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced minerals identification and characterization.
BRKR: 22.37 (-0.18)
Bruker Collaborates with CDC to Advance Infectious Disease Surveillance
PR Newswire - Thu Jun 16, 6:00AM CDT
At the American Society for Microbiology (ASM) Microbe 2016 conference, Bruker today announces the results of a successful collaboration with the Special Bacteriology Reference Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia to create an expanded microorganism reference library for the Bruker MALDI Biotyper.
BRKR: 22.37 (-0.18)
Bruker and 3M Expand Exclusive License for Processing of FFPE Tissue Sections to Routine Pathology
PR Newswire - Sun Sep 25, 3:30AM CDT
At the 28th Congress of the European Society of Pathology, Bruker today announces that it has expanded its license agreement with 3M for processing of FFPE tissue sections.
BRKR: 22.37 (-0.18)
Bruker Introduces the new TRACER 5i Handheld XRF Elemental Analyzer System for Advanced Applications and Research
PR Newswire - Thu Sep 15, 6:00AM CDT
Bruker today introduces the new TRACER(TM) 5i handheld X-ray fluorescence (XRF) elemental analyzer. The new TRACER 5i is more sensitive, flexible and field interactive, while retaining the unique advantages and comprehensive analytical software that the previous TRACER model has been recognized for. The new TRACER 5i incorporates a more powerful tube and detector, an automated filter wheel and a manual filter slot, selectable collimation, Bruker's patented SharpBeam(TM) optimized geometry, pressure and temperature compensation, an internal VGA CMOS camera, an interactive touchscreen with point-and-shoot capability, and Wi-Fi & Bluetooth connectivity.
BRKR: 22.37 (-0.18)
SENAI Outfits New Tribology Lab with Bruker UMT TriboLab Systems
PR Newswire - Tue Sep 13, 6:00AM CDT
Bruker has announced the installation of six UMT TriboLab Mechanical Testers at the Tribology Laboratory of Innovation SENAI Institute for Surface Engineering in Belo Horizonte, Brazil. Established by Brazil's National Service of Industrial Training (SENAI), the new state-of-the-art laboratory will utilize the TriboLab systems to carry out research and development of products focused on the evaluation of materials performance for resistance to wear. The TriboLab systems enable the new laboratory to test real-use conditions across an extremely wide range of industrial products, from automotive engine components and hydraulic pumps to cutting tools and aeronautical turbines.
BRKR: 22.37 (-0.18)
Bruker to Buy Oncovision's Preclinical Imaging Business
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 9:48AM CDT
Bruker entered into an agreement to acquire Oncovision's preclinical PET (Positron Emission Tomography) imaging business.
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), BRKR: 22.37 (-0.18), NUVA: 66.77 (-1.29)
Bruker Signs Agreement to Acquire Oncovision's Preclinical PET Imaging Business
PR Newswire - Wed Sep 07, 6:00AM CDT
Bruker today announced that it has signed an agreement to acquire the preclinical imaging business of Oncovision, a leading provider of innovative medical imaging devices used for the diagnosis of cancer. Financial terms of the agreement were not disclosed.
BRKR: 22.37 (-0.18)
Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress
PR Newswire - Wed Sep 07, 6:00AM CDT
Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 (WMIC: http://www.wmis.org) in New York. The new systems are designed to deliver highest performance and improved convenience for routine imaging, and enable novel translational research into the causes, progression, as well as potential diagnosis and treatment of disease.
BRKR: 22.37 (-0.18)
Research Reports Initiation on Medical Laboratories & Research Stocks -- Quest Diagnostics, Bruker, Organovo, and Alere
PR Newswire - Wed Aug 31, 7:00AM CDT
Stock-Callers.com draws investors' attention to these Medical Laboratories and Research equities: Quest Diagnostics Inc. (NYSE: DGX), Bruker Corp. (NASDAQ: BRKR), Organovo Holdings Inc. (NASDAQ: ONVO), and Alere Inc. (NYSE: ALR). Industry growth is influenced by a number of trends, which include demographics, emerging economies, biotech advances in genetics, and pathogen evolution. Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
ONVO: 3.97 (-0.03), DGX: 85.44 (-0.29), BRKR: 22.37 (-0.18), ALR: 43.24 (-0.43)
Bruker Corporation to Present at Investor Conferences
PR Newswire - Wed Aug 31, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:
BRKR: 22.37 (-0.18), WFC: 45.74 (+0.02)
Short Interest In Bruker Declines 17%
MarketNewsVideo.com - Thu Aug 25, 2:29PM CDT
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 751,751 share decrease in total short interest for Bruker Corp , to 3,678,038, a decrease of 16.97% since 07/29/2016. Total short interest is...
BRKR: 22.37 (-0.18)
Bruker's Q2 Results Disappoint, Product Launches Continue
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:14AM CDT
On Aug 12, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), BRKR: 22.37 (-0.18), NUVA: 66.77 (-1.29)
FlavorActiV and Bruker Announce Flavor Stability Partnership at World Brewing Congress
PR Newswire - Mon Aug 15, 8:30AM CDT
At the World Brewing Congress (www.worldbrewingcongress.org) in Denver, USA, FlavorActiV and Bruker Corporation (NASDAQ: BRKR) announced their strategic partnership and the launch of the Flavor Stability Package, by combining world-class beer sensory know-how with consistent tools and proven Bruker e-scan(TM) EPR technology.
BRKR: 22.37 (-0.18)
Bruker Announces Quarterly Dividend
PR Newswire - Tue Aug 09, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on September 23, 2016 to stockholders of record as of September 6, 2016.
BRKR: 22.37 (-0.18)
Bruker (BRKR) Posts In-Line Q2 Earnings, Misses Sales
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:29AM CDT
Bruker's (BRKR) second quarter earnings came in line with the Zacks Consensus Estimate, while revenues missed the mark.
BABY: 43.99 (-0.39), MASI: 59.77 (-0.55), BRKR: 22.37 (-0.18), IDXX: 111.36 (-1.73)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:52AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Outperform to Market Perform at Wells Fargo today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. Bruker share prices have moved between a 52-week high of $29.85 and a 52-week low of $15.78 and closed yesterday at 38% above that low price at $21.79 per share. The 200-day and 50-day moving averages have moved 0.62% higher and 0.71% higher over the past week, respectively.
BRKR: 22.37 (-0.18)
Upgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:50AM CDT
Bruker (NASDAQ:BRKR) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. There is potential upside of 2.0% for shares of Bruker based on a current price of $21.79 and an average consensus analyst price target of $22.23. The stock should find initial resistance at its 200-day moving average (MA) of $22.60 and further resistance at its 50-day MA of $28.13.
BRKR: 22.37 (-0.18)
SmarTrend Watching for Potential Rebound in Shares of Bruker After 12.06% Loss
Comtex SmarTrend(R) - Wed Aug 03, 1:56PM CDT
Bruker (NASDAQ:BRKR) traded in a range yesterday that spanned from a low of $21.38 to a high of $22.93. Yesterday, the shares fell 12.1%, which took the trading range below the 3-day low of $24.31 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BRKR: 22.37 (-0.18)
Bruker Reports Second Quarter 2016 Financial Results
PR Newswire - Tue Aug 02, 3:05PM CDT
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its second quarter ended June 30, 2016.
BRKR: 22.37 (-0.18)
Bruker Acquires Software Assets for Next-Generation Automated and Quantitative Mineral Identification and Characterization
PR Newswire - Mon Jun 20, 6:00AM CDT
Bruker today announced that it has acquired the assets of Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced minerals identification and characterization.
BRKR: 22.37 (-0.18)
Bruker Collaborates with CDC to Advance Infectious Disease Surveillance
PR Newswire - Thu Jun 16, 6:00AM CDT
At the American Society for Microbiology (ASM) Microbe 2016 conference, Bruker today announces the results of a successful collaboration with the Special Bacteriology Reference Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia to create an expanded microorganism reference library for the Bruker MALDI Biotyper.
BRKR: 22.37 (-0.18)
(0)
(0)Scroll down for more posts ▼